Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council on  Drug Abuse.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meeting will be closed to the public  in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning  individuals associated with grant applications, the disclosure of which  would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Advisory Council on  Drug Abuse.                     

*Date:*                         May 16-17, 2000.                    

*Open:*                         May 16, 2000, 1 p.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Neuroscience Center, National Institutes of Health, 6001 Executive Blvd., Bethesda, MD 20892.                    

*Open:*                         May 17,  2000, 9 a.m. to 11:30 a.m.                    

*Agenda:*                         This portion of the meeting will be open to the public for announcements and reports of administrative, legislative and program developments in the drug abuse field.                    

*Place:*                         Neuroscience Center, National Institutes of Health, 6001 Executive Blvd., Bethesda, MD 20892.                    

*Contact Person:*                         Teresa Levitin, Director, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, Bethesda, MD 20892-9547, (301) 443-2755.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National  Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS)

Dated: April 20, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-10412  Filed 4-25-00; 8:45 am]

BILLING CODE 4140-01-M